Hanninen M, Venner P, North S. A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer. CUAJ [Internet]. 2013 May 1 [cited 2024 May 10];3(5):369-74. Available from: https://cuaj.ca/index.php/journal/article/view/1145